Acquired osteosclerosis associated with intravenous drug use and hepatitis C infection

Bone

Volumn 19, Issue 6, 1996, Pages 679-683

  Diamond, T ^a   Depczynski, Barbara ^b  

^a ST GEORGE HOSPITAL   (Australia)

^b ST VINCENT S HOSPITAL   (Australia)

Author keywords

Drug abuse; Hepatitis C; Osteosclerosis; Pamidronate; Viruses

Indexed keywords

BIOCHEMICAL MARKER; ETIDRONIC ACID; HEPATITIS C ANTIBODY; HYDROXYPROLINE; OSTEOCALCIN; PAMIDRONIC ACID;

ADULT; ANTIBODY DETECTION; ARTICLE; BONE BIOPSY; BONE DENSITY; BONE MINERAL; BONE PAIN; CASE REPORT; CLINICAL FEATURE; CORTICAL BONE; HEPATITIS C; HUMAN; HYDROXYPROLINE URINE LEVEL; INTRAVENOUS DRUG ABUSE; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; OSTEOSCLEROSIS; RADIODIAGNOSIS; TRABECULAR BONE;

ADULT; BONE DENSITY; BONE DISEASES; DIPHOSPHONATES; FEMUR; HEPATITIS C; HUMANS; LUMBAR VERTEBRAE; MALE; OSTEOSCLEROSIS; SUBSTANCE ABUSE, INTRAVENOUS;

EID: 0030463541     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/S8756-3282(96)00304-3     Document Type: Article

References (21)

1. 1. Beyer, H. S., Andersen, Q., Shih, M. S., Parfitt, A. M., and Heath, H. Diffuse osteosclerosis in intravenous drug abusers. Am J Med 95:60-661; 1993.
2. 2. Beyer, H. S., Parfitt, A. M., Shih, M. S., Anderson, Q., and Heath, H. Case report idiopathic acquired diffuse osteosclerosis in a young woman. J Bone Miner Res 5:1257-1263; 1990.
3. 3. Cartwright, E. J., Gordon, M. T., Freemont, A. J., Anderson, D. C., and Sharpe, P. T. Paramyxoviruses and Paget's disease. J Med Virol 40:133-141; 1993.
4. 4. Davis, G. L., Lau, J. Y. N., and Lim, H. L. Therapy for chronic hepatitis C. Gastroenterol Clin North Am 23:603-611; 1994.
5. 5. Diamond, T. H., Steil, D., Lunzer, M., McDowall, D., Eckstein, R. P., and Posen, S. Hepatic osteodystrophy static and dynamic bone histomorpnometry and serum bone Gla-Protein in 80 patients with chronic liver disease. Gastroenterology 96:213-221; 1989.
6. 6. Hassoun, A., Nippoldt, T. B., Tiegs, R. D., and Khosla, S. Hepatitis C associated osteosclerosis. J Bone Miner Res 10(suppl 1):S404 (Abstract); 1995.
7. 7. Hewison, M. Vitamin D and the immune system. J Endocrinol 132:173-175; 1992.
8. 8. Khosla, S., Hassoun, A., and Heath, H., III. Osteosclerosis in intravenous drug abusers. Endocrinologist 5:339-343; 1995.
9. 9. Klimas, N. G., Blaney, N. T, Morgan, R. O., Chitwood, D., Milles, K., Lee, H., and Fletcher, M. A. Immune function and anti-HTLV-I/II status in anti-HIV-1-negative intravenous drug users receiving methadone. Am J Med 90:163-170; 1991.
10. 10. Manzke, E., Gruber, H. E., Hiness, R. W., and Baylink, D. J. Skeletal remodelling and bone related hormones in two adults with increased bone mass. Metabolism 31:25-32; 1982.
11. 11. Metcalf, D., Willson, T., Rossner, M., and Lock, P. Receptor insertion into factor-dependent murine cell lines to develop specific bioassays for murine G-CSF and M-CSF and human GM-CSF. Growth Factors 11:145-152; 1994.
12. 12. Novick, D. M., Ochshorn, M., and Kreek, M. J. In vivo and in vitro studies of opiates and cellular immunity in narcotic addicts. In: Friedman, H., Specter, S., and Klein T. W., Eds. Advances in experimental medicine and biology. Vol. 288. Drugs of Abuse, Immunity and Immunodeficiency. New York: Plenum; 1991; 159-170.
13. 13. Pawlotsky, J., Yahia, M. B., Andre, C., Voisin, M., Intrator, L., Roudot-Thoraval, F., Deforges, L., Duvoux, C., Zafrani, E., Duval, J., and Dhumeaux, D. Immunological disorders in C virus chronic active hepatitis: A prospective case-control study. Hepatology 19:841-848; 1994.
14. 14. Sivera, P., Cesano, L., Guerrasio, A., Camashella, C., and Mazza, U. Clinical and haematological improvement induced by etidronate in a patient with idiopathic myelofibrosis and osteosclerosis. Br J Haematol 86:397-398; 1994.
15. 15. Smith, B. C., Strasser, S. I., and Desmond, P. V. Current perspectives in hepatitis C. Aust N Z J Med 25:350-357; 1995.
16. 16. Treves, R., Naveau, B., Miravet, L., and Leboutet, M. J. Idiopathic Osteopetrosis: A new case. Bone Miner 17(suppl 1): 188; 1992 (abstract).
17. 17. Villareal, D. T., Murphy, W. A., Teitelbaum, S. T., Arens, M. Q., and Whyte, M. P. Painful diffuse osteosclerosis after intravenous drug abuse. Am J Med 93:371-381; 1992.
18. 18. Wybran, J., Appelboom, T., Famaey, J. P., and Govaerts, A. Suggestive evidence for receptors for morphine and methionine-enkephalin on normal human blood T lymphocytes. J lmmunol 123:1068-1070; 1979.
19. 19. Whyte, M. P. Sclerosing bone dysplasias. Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism. In: Favus, M. J., Ed. New York: Raven; 1993;327-344.
20. 20. Whyte, M. P., Teitelbaum, S. L., and Reinus, W. R. Doubling skeletal mass during adult life: The syndrome of diffuse osteosclerosis after intravenous drug abuse. J Bone Miner Res 11:554-558; 1996.
21. 21. Whyte, M. P., Murphy, W. A., Villareal, D. T., Teitelbaum, S. L., and Arens, M. Q. Diffuse osteosclerosis in intravenous drug abusers (reply). Am J Med 95:661-662; 1993(Letter).